Plus Therapeutics, Inc. (PSTV) SEC Filings — 2024
19 SEC filings for Plus Therapeutics, Inc. (PSTV) in 2024.
Filings
- Plus Therapeutics Files 8-K, Updates Corporate Information — 8-K · Nov 14, 2024
- Plus Therapeutics Relocates Principal Executive Offices — 8-K · Nov 1, 2024
- Plus Therapeutics Faces Nasdaq Delisting Warning — 8-K · Sep 6, 2024
- PLUS THERAPEUTICS Files 8-K on Security Holder Vote — 8-K · Aug 15, 2024
- Plus Therapeutics Reports Q2 2024 Results — 10-Q · Aug 14, 2024
- Plus Therapeutics Files Proxy Materials — DEFA14A · Jul 12, 2024
- Plus Therapeutics Files Definitive Proxy Statement — DEF 14A · Jul 10, 2024
- Plus Therapeutics Files S-1/A Amendment — S-1/A · Jun 24, 2024
- Plus Therapeutics Files S-1, Updates Financials — S-1 · Jun 7, 2024
- Plus Therapeutics Appoints New Directors, Updates Executive Contracts — 8-K · Jun 7, 2024
- Plus Therapeutics, Inc. SC 13G Filing — SC 13G · Jun 5, 2024
- Plus Therapeutics Enters New Agreement, Terminates Old One — 8-K · Jun 4, 2024
- PLUS THERAPEUTICS Files 8-K on Shareholder Nominations — 8-K · May 20, 2024
- Plus Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- PLUS THERAPEUTICS FILES 8-K WITH MATERIAL AGREEMENT — 8-K · May 9, 2024
- Plus Therapeutics Faces Delisting Concerns — 8-K · Mar 14, 2024
- Plus Therapeutics Files 8-K — 8-K · Mar 13, 2024
- Plus Therapeutics, Inc. Files Amendment to S-1 Registration Statement — S-1/A · Mar 8, 2024
- Plus Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024